Disc Medicine, Inc. Quarterly Operating Income (Loss) in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Disc Medicine, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q2 2024.
  • Disc Medicine, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$30.9M, a 78% decline year-over-year.
  • Disc Medicine, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$111M, a 63.3% decline year-over-year.
  • Disc Medicine, Inc. annual Operating Income (Loss) for 2023 was -$91.1M, a 91.9% decline from 2022.
  • Disc Medicine, Inc. annual Operating Income (Loss) for 2022 was -$47.5M, a 53.5% decline from 2021.
  • Disc Medicine, Inc. annual Operating Income (Loss) for 2021 was -$30.9M, a 9.13% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$111M -$30.9M -$13.5M -78% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$97.5M -$31.5M -$6.34M -25.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$91.1M -$29.7M -$14.7M -97.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$76.4M -$19M -$8.48M -80.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$68M -$17.3M -$5.31M -44.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$62.6M -$25.1M -$15.2M -152% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$47.5M -$15M -$35.3M -174% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$12.1M -$10.5M +$7.97M +43.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$20.1M -$12M +$4.31M +26.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$24.4M -$9.96M +$6.53M +39.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$30.9M $20.3M +$30.1M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$61.1M -$18.5M -$10.5M -132% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$50.6M -$16.3M -$9.65M -145% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$40.9M -$16.5M -$6.86M -71.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$34M -$9.79M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 -$7.95M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$6.67M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$9.63M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.